Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Pan-cancer atlas of somatic core and linker histone mutations. | NPJ Genom Med | 2023 | 37640703 | PubTator, text mining | PubMed |
| HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. | Nucleic Acids Res | 2023 | 37638746 | PubTator, text mining | PubMed |
| Identification of Radiomic Signatures in Brain MRI Sequences T1 and T2 That Differentiate Tumor Regions of Midline Gliomas with H3.3K27M Mutation. | Diagnostics (Basel) | 2023 | 37627927 | PubTator, text mining | PubMed |
| Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma. | Neoplasia | 2023 | 37603953 | PubTator, text mining | PubMed |
| Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex media. | Sci Rep | 2023 | 37587235 | PubTator, text mining | PubMed |
| Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. | Front Immunol | 2023 | 37575240 | PubTator, text mining | PubMed |
| Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity. | Cancers (Basel) | 2023 | 37568598 | PubTator, text mining | PubMed |
| Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing. | Medicine (Baltimore) | 2023 | 37565864 | PubTator, text mining | PubMed |
| REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial. | Mol Cancer | 2023 | 37559050 | PubTator, text mining | PubMed |
| DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics. | J Pathol Clin Res | 2023 | 37555357 | PubTator, text mining | PubMed |
| Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review. | Front Mol Neurosci | 2023 | 37547920 | PubTator, text mining | PubMed |
| A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. | Acta Neuropathol | 2023 | 37524847 | PubTator, text mining | PubMed |
| LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer. | Front Genet | 2023 | 37519886 | PubTator, text mining | PubMed |
| H3G34-Mutant Gliomas-A Review of Molecular Pathogenesis and Therapeutic Options. | Biomedicines | 2023 | 37509641 | PubTator, text mining | PubMed |
| Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations. | Brain Sci | 2023 | 37509034 | PubTator, text mining | PubMed |
| Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma. | Neurooncol Adv | 2023 | 37497017 | PubTator, text mining | PubMed |
| The emerging role of snoRNAs in human disease. | Genes Dis | 2023 | 37492704 | PubTator, text mining | PubMed |
| OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 | 37492101 | PubTator, text mining | PubMed |
| Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors. | Front Oncol | 2023 | 37483487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=12